323. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms,

management and adjuvant therapy. Br J Surg 1994; 81(1):7–19.

324. Bozzetti F, Bertario L, Rossetti C, et al. Surgical treatment of locally recurrent rectal carcinoma. Dis

Colon Rectum 1997;40(12):1421–1424.

325. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total

mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised

controlled TME trial. Lancet Oncol 2011;12(6):575–582.

326. Tepper JE, O’Connell M, Hollis D, et al. Analysis of surgical salvage after failure of primary

therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003;21(19):3623–3628.

327. Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally

recurrent rectal cancer. Dis Colon Rectum 1999;42(7):886–893; discussion 93–95.

328. Balbay MD, Slaton JW, Trane N, et al. Rationale for bladder-sparing surgery in patients with locally

advanced colorectal carcinoma. Cancer 1999;86(11):2212–2216.

329. Tan E, Gouvas N, Nicholls RJ, et al. Diagnostic precision of carcinoembryonic antigen in the

detection of recurrence of colorectal cancer. Surg Oncol 2009;18(1):15–24.

330. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen

measurement and computed tomography in the surveillance of patients after adjuvant

chemotherapy for colorectal cancer. J Clin Oncol 2004;22(8):1420–1429.

331. Lambregts DM, Cappendijk VC, Maas M, et al. Value of MRI and diffusion-weighted MRI for the

diagnosis of locally recurrent rectal cancer. Eur Radiol 2011;21(6):1250–1258.

332. de Anda EH, Lee SH, Finne CO, et al. Endorectal ultrasound in the follow-up of rectal cancer

patients treated by local excision or radical surgery. Dis Colon Rectum 2004;47(6):818–824.

333. Maas M, Rutten IJ, Nelemans PJ, et al. What is the most accurate whole-body imaging modality for

assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for

recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2011;38(8):1560–1571.

334. Schmidt GP, Baur-Melnyk A, Haug A, et al. Whole-body MRI at 1.5 T and 3 T compared with FDGPET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol

2009;19(6):1366–1378.

335. Lu YY, Chen JH, Chien CR, et al. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer

in patients with elevated CEA: a systematic review and meta-analysis. Int J Colorectal Dis

2013;28(8):1039–1047.

1827

336. Vermaas M, Nuyttens JJ, Ferenschild FT, et al. Reirradiation, surgery and IORT for recurrent rectal

cancer in previously irradiated patients. Radiother Oncol 2008;87(3):357–360.

337. Garcia-Aguilar J, Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer. Dis

Colon Rectum 2001;44(12):1743–1748.

1828